Why do people believe in conspiracy theories? First, we
Why do people believe in conspiracy theories? First, we humans have cognitive biases that make believing in conspiracy theories easy. We have a tendency to see patterns where none exist, and we interpret new information and recall old information in ways that confirm our already-held expectations and beliefs.
The problem is that it's easier to say "naked shorts" than it is to say "I got here too early". Many posters here know for a fact that they are smarter than the market. When the market corrects their misconception they deny their incorrectness and instead blame an invisible, imaginary enemy. Anyone who who disagrees must be a part of the conspiracy.
A naked short conpsiracy is not necessary to explain the price action the past two years though. Look at what has happened the past two years:
-Losing funding for a phase 2 (K at UoB - good preclinical stuff out about two years after we expected to start a funded phase 2 in AML)
-Having to do a phase 2b in order to get a maximum value partnership (Prurisol)
-Suffering massive delays in the B-OM trial completion completion.
-Indefinitely holding off on the crown jewel B-ABSSSI phase 3.
-Depending on the stock price for funding in the face of two large sellers (Aruda/Aspire) and high profile SA hit jobs along with a frivolous lawsuit.
It's easy to see how this company lost momentum. The only counterbalance to these over the last two years has been the outstanding B-UP results and the recruitment of Dr. Bertolino. I expect these will prove to have been transformative to the company in a big way but have not reflected in the stock price yet.
Heading into 2H 2017 we finally catch a glimpse of catalysts that can revive us. With any luck we will have good results in up to four phase 2 trials and possibly even one or more partnerships.
No need for naked shorts. We changed course, suffered delays, suffered several hatchet jobs and got sued....all with a minimal cash balance and declining shareprice. The turn around cometh but our path was not completely unforeseen.
The prophecy spoke of the road we have walked and the road we will walk. Do not waver.
Go IPIX!
2
2
Innovation Pharmaceuticals Inc (IPIX) Stock Research Links
All my posts are my own personal opinion and speculation. They should not be used as the basis for any investment decision. No, I am not Scottsmith.
Scroll down for more posts ▼
Top 10 Most Recent News Articles
The State of Compensation in AEC Sit back and chew on this—AEC firms are playing a whole new ball game when it comes to compensating their talent. FMI Corporation’s 2026 Compensation Trends Study is putting a spotlight on what really goes on behind the scenes in architecture, engineering, and construction firms. This is about more than just tossing some coin for a...
Continue Reading
Boosting Connectivity for Student-Athletes Here's a nugget that slips under the radar unless you're looking with both eyes open: Scientel Solutions, from Aurora, Illinois, is shaking up the connectivity game for North Central College's athletic department. These folks have realized something many don't quite grasp—keeping student-athletes connected is no luxury; it's...
Continue Reading
Huawei's Bold Move in Munich When I hear about yet another product launch, I often roll my eyes but this one, folks, deserves a second glance. Huawei dropped a news bomb in Munich with their 'Chase the Wild' event, unveiling a huge lineup of flagship gadgets. This isn't your run-of-the-mill release; the mix of smart wearables, tablets, smartphones, and audio gear marks...
Continue Reading
Revolutionizing Healthcare Payment with AI Ah, healthcare and payments—two things that can make even the most patient folks lose their cool. But here comes Codoxo, shaking up this landscape with its Point Zero Payment Integrity solution, and someone's finally giving them the nod they deserve. For those of us who have been in the game for a while, this announcement is...
Continue Reading
Fasten your seatbelts, folks—because there's a tinge of burnt rubber in the air at Columbus's Polaris Center. Supercharged Entertainment, the big guns in indoor karting, just kicked off construction at their brand-new venue, and it’s looking like a gearhead's paradise. A sprawling 16-acre parcel is set to become a haven for adrenaline junkies come Summer 2027. A Bold...
Continue Reading
DeFi Must Step Up To Meet Compliance Challenge Alright, folks, here's the scoop: DeFi Technologies just picked up another 180 days from Nasdaq to get its act together and hit that crucial one-buck minimum bid price. It's like getting extra time on a pop quiz you forgot to study for—useful, but no guarantee they'll pass. What Led to the Extra Time? These guys over at...
Continue Reading
A Fresh Sweep with AI: Narwal's 2026 Lineup Hot off the press from Berlin's IFA 2026, Narwal is making some serious waves with its latest household cleaning gadgets. This isn't just another batch of robot helpers; Narwal's aiming to redefine what AI-driven cleaning can do for your home. FlowWash: Not Just Another Cleaning Gimmick Narwal's been at this game for over a...
Continue Reading
Capricor Therapeutics: A Rough Road Ahead If you've got skin in the game with Capricor Therapeutics, these latest developments might have you feeling a bit queasy. Forget the greasy diner fare today; this situation calls for some serious contemplation and maybe a bit of antacid. Over at NASDAQ:CAPR, the air is hot with allegations, stock price nosedives, and looming legal...
Continue Reading
Award for Exceptional Vision Care Leadership Ain't every day you see a politician scooping up awards for making a real difference in folks' lives. Yet here we are, tipping our hats to Ohio's Governor Mike DeWine, who's just been dubbed the honcho with the golden eye for children's vision care in the 12th annual Bonnie Strickland Champion for Children's Vision Award. Hats...
Continue Reading
Mitrade's New Insurance: A Safety Net? Mitrade EU is amping up its game with some fresh insurance perks that catch the eye. They're slapping on some extra insolvency protection for clients trading under their CySEC license. Now that sounds like a financial shield anyone would want. Basically, they're adding another layer to the basic regulatory protections, and without...
Continue Reading
Top 5 Most Recently Viewed Articles
Supernus Pharmaceuticals Announces FDA Acceptance of SPN-830 Apomorphine Infusion Device NDA PDUFA Target Action Date: February 1, 2025 ROCKVILLE, Md. — Supernus Pharmaceuticals, Inc. (Nasdaq: SUPN), a biopharmaceutical company focused on developing and commercializing treatments for central nervous system (CNS) disorders, has announced that the U.S. Food and Drug...
Continue Reading
Ocean Power Technologies Expands with New Office in D.C. Ocean Power Technologies, Inc. (NYSE American: OPTT), a frontrunner in innovative offshore power solutions, has proudly announced the opening of its new office at the Association for Uncrewed Vehicle Systems International (AUVSI) headquarters in Washington, D.C. This exciting development aligns with the company’s...
Continue Reading
Gold Prices Reach New Highs Gold prices have surged to striking new levels during Asian trading, hitting an all-time high as markets respond to the anticipation of interest rate cuts by the Federal Reserve. This upward trend comes amid a notable rise in demand for the precious metal, which investors often turn to in uncertain times. The current speculation revolves around...
Continue Reading
Union Pacific Corporation Analyst Upgrade Insights Analysts at major financial institutions have recently reassessed their positions on a selection of prominent stocks, including Union Pacific Corporation (NYSE: UNP). This change in outlook comes as many market players look for emerging opportunities in a shifting economic landscape. An Upgrade in Perspective Rick...
Continue Reading
Progressive Planet Posts Profitable Q1 and Growth Plans Progressive Planet Solutions Inc. has shared impressive financial results for its first quarter, showing a notable turnaround with profitable outcomes. The company reported an EBITDA of $743K for this period, which marks a significant improvement from the $113K loss recorded last year. This positive change...
Continue Reading